Solarea Bio
Solarea Bio innovates microbial solutions for human health, focusing on aging-related conditions. The company develops products addressing dietary needs related to rheumatoid arthritis, psoriatic arthritis, and other inflammatory conditions associated with aging, leveraging microbiome science to advance health outcomes. Founded in 2017 and headquartered in Cambridge, United States, Solarea Bio has raised…
Funding snapshot
About
Solarea Bio innovates microbial solutions for human health, focusing on aging-related conditions. The company develops products addressing dietary needs related to rheumatoid arthritis, psoriatic arthritis, and other inflammatory conditions associated with aging, leveraging microbiome science to advance health outcomes. Founded in 2017 and headquartered in Cambridge, United States, Solarea Bio has raised approximately $37.2M in Series B funding from investors including Illumina, Bold Capital Partners, Viking Global Investors, S2G Investments, Joyance Partners, and Rising Tide Fund. The company combines microbiome research with nutritional science to develop bioactive products that modulate the gut microbiome for therapeutic benefit, addressing the growing intersection of nutrition and medicine for aging populations seeking to maintain mobility and quality of life through microbiome-targeted interventions.
Business model
Gastroenterology > Drugs > Diversified,
Genomics > Applied Genomics > Clinical Genomics > Therapeutics,
Nutraceuticals Tech > Functional Foods and Beverages
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.